BIOLINQ INC

Profile

Company Names

BIOLINQ INC

Addresses

10260 SORRENTO VALLEY ROAD, SAN DIEGO, CA 92121

4535 TOWNE CENTRE COURT, SUITE 200, SAN DIEGO, CA 92121

4535 TOWNE CENTRE CT STE 200, SAN DIEGO, CA 92121

4535 TOWNE CENTRE CT #200, SAN DIEGO, CA 92121

6191 CORNERSTONE CT EAST, SUITE 109, SAN DIEGO, CA 92121

Phone Numbers

(510) 847-9655
5108479655

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$247,430,582.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2025-03-07 
$90,000,000.00 
$100,000,000.00 
$10,000,000.00 
Equity 
7
2023-12-13 
$59,139,615.00 
$59,139,615.00 
$0.00 
Debt 
6
2021-09-02 
$77,946,902.00 
$105,609,392.00 
$27,662,490.00 
Equity 
5
2021-03-16 
$5,223,811.00 
$6,000,000.00 
$776,189.00 
Debt 
4
2020-03-25 
$3,554,335.00 
$10,000,000.00 
$6,445,665.00 
Debt 
3
2019-03-13 
$3,000,000.00 
$3,000,000.00 
$0.00 
Equity 
2
2017-11-14 
$8,115,919.00 
$13,115,919.00 
$5,000,000.00 
Equity 
1
2016-09-16 
$450,000.00 
$750,000.00 
$300,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
 
ARIDA 
EXECUTIVE OFFICER
ZINA 
AFFAS 
BESSE 
DIRECTOR
DAN 
 
BRADBURY 
DIRECTOR
DANIEL 
 
BRADBURY 
DIRECTOR
CHRIS 
 
DIMITROPOULOS 
DIRECTOR
LANA 
 
GHANEM 
DIRECTOR
NANCY 
 
HONG 
DIRECTOR
THAD 
 
JOHNSON 
DIRECTOR
EDWARD 
 
KLIPHUIS 
DIRECTOR
DEREK 
 
RAPP 
DIRECTOR
JARED 
 
TANGNEY 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
JARED 
AFFAS 
TANGNEY 
EXECUTIVE OFFICER
JOSHUA 
 
WINDMILLER 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
RICHARD 
 
YANG 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-03-07 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-12-13 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-12-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-12-13 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-09-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-03-16 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-03-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-03-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-14 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-09-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
J.P. MORGAN SECURITIES LLC
79
COVINGTON ASSOCIATES, LLC
THOMAS MARK CIBOTTI